Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$16.15 - $42.35 $606,933 - $1.59 Million
-37,581 Reduced 19.68%
153,406 $2.48 Million
Q2 2023

Aug 09, 2023

SELL
$40.29 - $82.51 $244,278 - $500,258
-6,063 Reduced 3.08%
190,987 $7.93 Million
Q1 2023

May 12, 2023

SELL
$56.44 - $118.81 $1.78 Million - $3.75 Million
-31,603 Reduced 13.82%
197,050 $11.9 Million
Q4 2022

Feb 08, 2023

BUY
$63.98 - $85.37 $1.23 Million - $1.64 Million
19,246 Added 9.19%
228,653 $16.8 Million
Q3 2022

Nov 09, 2022

BUY
$67.99 - $89.57 $1.61 Million - $2.12 Million
23,686 Added 12.75%
209,407 $15.9 Million
Q2 2022

Aug 10, 2022

SELL
$56.6 - $89.9 $474,817 - $754,171
-8,389 Reduced 4.32%
185,721 $12.9 Million
Q1 2022

May 04, 2022

SELL
$60.15 - $84.52 $2 Million - $2.81 Million
-33,285 Reduced 14.64%
194,110 $16.1 Million
Q4 2021

Feb 10, 2022

SELL
$75.08 - $121.99 $91,597 - $148,827
-1,220 Reduced 0.53%
227,395 $17.1 Million
Q3 2021

Nov 10, 2021

SELL
$116.17 - $194.55 $316,214 - $529,565
-2,722 Reduced 1.18%
228,615 $26.6 Million
Q2 2021

Aug 13, 2021

SELL
$130.4 - $225.58 $1.03 Million - $1.79 Million
-7,934 Reduced 3.32%
231,337 $51.3 Million
Q1 2021

May 14, 2021

BUY
$124.11 - $190.17 $2.14 Million - $3.28 Million
17,273 Added 7.78%
239,271 $31.6 Million
Q4 2020

Feb 02, 2021

BUY
$112.16 - $174.14 $1.5 Million - $2.32 Million
13,335 Added 6.39%
221,998 $38.4 Million
Q3 2020

Nov 05, 2020

SELL
$58.05 - $111.31 $842,711 - $1.62 Million
-14,517 Reduced 6.5%
208,663 $23.2 Million
Q2 2020

Aug 12, 2020

BUY
$57.2 - $74.41 $1.59 Million - $2.07 Million
27,777 Added 14.22%
223,180 $13.2 Million
Q1 2020

May 12, 2020

SELL
$57.05 - $95.75 $2.16 Million - $3.63 Million
-37,879 Reduced 16.24%
195,403 $13.2 Million
Q4 2019

Jan 27, 2020

BUY
$68.3 - $93.8 $2.99 Million - $4.1 Million
43,710 Added 23.06%
233,282 $19.7 Million
Q3 2019

Oct 31, 2019

BUY
$61.86 - $97.8 $3.09 Million - $4.88 Million
49,924 Added 35.75%
189,572 $14.2 Million
Q2 2019

Aug 15, 2019

SELL
$42.22 - $63.23 $18,576 - $27,821
-440 Reduced 0.31%
139,648 $8.83 Million
Q1 2019

May 03, 2019

SELL
$31.96 - $56.12 $51,136 - $89,792
-1,600 Reduced 1.13%
140,088 $6.75 Million
Q4 2018

Feb 08, 2019

SELL
$28.72 - $52.63 $142,077 - $260,360
-4,947 Reduced 3.37%
141,688 $4.74 Million
Q3 2018

Nov 13, 2018

BUY
$32.0 - $52.4 $2.51 Million - $4.11 Million
78,514 Added 115.26%
146,635 $7.68 Million
Q2 2018

Aug 15, 2018

SELL
$19.85 - $32.0 $356,922 - $575,392
-17,981 Reduced 20.88%
68,121 $2.13 Million
Q1 2018

May 11, 2018

BUY
$19.3 - $23.65 $1.66 Million - $2.04 Million
86,102 New
86,102 $1.88 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.